2026 Q1 Portfolio Activity
In 2026 Q1, SECTORAL ASSET MANAGEMENT INC maintained a portfolio of 84 distinct positions. The most significant new addition was IQVIA HOLDINGS INC, now representing 1.17% of the total fund value. They heavily accumulated shares in GILEAD SCIENCES INC, increasing the position by 53.7%. Conversely, SECTORAL ASSET MANAGEMENT INC completely exited their position in ASTRAZENECA.
Position History
hover any row below to update
Loading…
Total Positions
84
Quarter
2026 Q1
Top Holding
EVMN (11.2%)
Top 10 Concentration
48.1%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 84
SECTORAL ASSET MANAGEMENT INC Full Holdings List — 2026 Q1
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EVMN
EVOMMUNE INC
|
Healthcare | 11.22% | 8.08% |
#1
Prev: #1
|
7.0 |
—
|
no change | no change |
P
S
|
589,005 | $13,541,225 |
$17.12
+36.3%
|
2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | ||
|
CTNM
CONTINEUM THERA...
|
Healthcare | 7.87% | 7.34% |
#2
Prev: #2
|
5.1 |
—
|
-73,200 | -9.1% |
P
S
|
727,587 | $9,502,286 | 2024 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
SI
SHOULDER INNOVA...
|
Unknown | 5.18% | 5.64% |
#3
1
Prev: #4
|
3.6 |
—
|
-62,028 | -12.6% |
P
S
|
430,407 | $6,253,814 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
LLY
ELI LILLY & CO
|
Healthcare | 4.84% | 6.27% |
#4
1
Prev: #3
|
2.9 |
—
|
-922 | -12.7% |
P
S
|
6,354 | $5,844,219 | 2005 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
JNJ
JOHNSON & JOHNS...
|
Healthcare | 3.69% | 3.37% |
#5
2
Prev: #7
|
2.5 |
—
|
-2,082 | -10.3% |
P
S
|
18,218 | $4,453,208 | 2009 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
GILD
GILEAD SCIENCES...
|
Healthcare | 3.42% | 1.76% |
#6
13
Prev: #19
|
4.4 |
—
|
9,605 | 53.7% |
P
S
|
27,490 | $4,131,624 | 2003 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
UNH
UNITEDHEALTH GR...
|
Healthcare | 3.35% | 3.60% |
#7
2
Prev: #5
|
3.3 |
—
|
1,362 | 10.0% |
P
S
|
14,957 | $4,047,215 | 2003 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
AMGN
AMGEN INC
|
Healthcare | 2.91% | 3.43% |
#8
2
Prev: #6
|
1.2 |
—
|
-3,860 | -29.5% |
P
S
|
9,210 | $3,514,982 | 2004 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
VRTX
VERTEX PHARMA
|
Healthcare | 2.86% | 2.91% |
#9
Prev: #9
|
1.6 |
—
|
-998 | -12.5% |
P
S
|
7,007 | $3,457,113 | 2004 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
INSM
INSMED INC
|
Healthcare | 2.80% | 1.56% |
#10
10
Prev: #20
|
4.1 |
—
|
8,486 | 75.9% |
P
S
|
19,668 | $3,380,776 | 2013 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ARGX
ARGENX SE
|
Healthcare | 2.27% | 1.95% |
#11
3
Prev: #14
|
3.4 |
—
|
670 | 23.2% |
P
S
|
3,564 | $2,736,977 | 2020 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ABBV
ABBVIE INC
|
Healthcare | 2.20% | 3.08% |
#12
4
Prev: #8
|
0.9 |
—
|
-4,600 | -27.4% |
P
S
|
12,200 | $2,653,378 | 2013 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ABT
ABBOTT LABS
|
Healthcare | 2.18% | 2.36% |
#13
3
Prev: #10
|
2.9 |
—
|
2,080 | 8.9% |
P
S
|
25,578 | $2,626,093 | 2008 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
MRK
MERCK & CO INC
|
Healthcare | 2.14% | 1.81% |
#14
4
Prev: #18
|
1.4 |
—
|
80 | 0.4% |
P
S
|
21,480 | $2,583,829 | 2008 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
REGN
REGENERON PHARM...
|
Healthcare | 2.06% | 2.30% |
#15
4
Prev: #11
|
0.8 |
—
|
-796 | -21.4% |
P
S
|
2,919 | $2,481,720 | 2012 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ISRG
INTUITIVE SURGI...
|
Healthcare | 2.00% | 2.20% |
#16
4
Prev: #12
|
2.8 |
—
|
400 | 8.2% |
P
S
|
5,250 | $2,420,198 | 2007 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
BSX
BOSTON SCIENTIF...
|
Healthcare | 1.81% | 2.11% |
#17
4
Prev: #13
|
3.2 |
—
|
7,154 | 25.9% |
P
S
|
34,780 | $2,182,445 | 2003 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
BNTX
BIONTECH SE
|
Healthcare | 1.69% | 1.31% |
#18
6
Prev: #24
|
3.2 |
—
|
4,946 | 28.7% |
P
S
|
22,164 | $2,045,307 | 2021 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
SYK
STRYKER CORP
|
Healthcare | 1.60% | 1.85% |
#19
3
Prev: #16
|
1.1 |
—
|
-676 | -10.3% |
P
S
|
5,874 | $1,930,138 | 2008 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
DHR
DANAHER CORP
|
Healthcare | 1.51% | 1.94% |
#20
5
Prev: #15
|
1.1 |
—
|
-978 | -9.2% |
P
S
|
9,597 | $1,819,591 | 2018 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
TMO
THERMO FISHER S...
|
Healthcare | 1.43% | 1.81% |
#21
4
Prev: #17
|
1.1 |
—
|
-392 | -10.1% |
P
S
|
3,508 | $1,724,287 | 2010 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
DXCM
DEXCOM INC
|
Healthcare | 1.21% | 1.53% |
#22
1
Prev: #21
|
1.0 |
—
|
-5,469 | -19.1% |
P
S
|
23,231 | $1,458,907 | 2008 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
IQV
IQVIA HOLDINGS ...
|
Healthcare | 1.17% | — |
#23
Prev: #—
|
4.0 |
—
|
8,307 | — |
NEW
|
8,307 | $1,416,676 | 2021 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
SMMT
SUMMIT THERAPEU...
|
Healthcare | 1.16% | 1.12% |
#24
3
Prev: #27
|
1.0 |
—
|
-10,010 | -12.6% |
P
S
|
69,615 | $1,399,627 | 2023 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
EW
EDWARDS LIFESCI...
|
Healthcare | 1.15% | 1.18% |
#25
Prev: #25
|
1.0 |
—
|
88 | 0.5% |
P
S
|
17,338 | $1,388,427 | 2010 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
BMY
BRISTOL MYERS S...
|
Healthcare | 1.06% | — |
#26
Prev: #—
|
3.9 |
—
|
21,150 | — |
NEW
|
21,150 | $1,282,748 | 2003 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
UTHR
UNITED THERAPEU...
|
Healthcare | 0.95% | 0.67% |
#27
13
Prev: #40
|
0.9 |
—
|
-13 | -0.8% |
P
S
|
1,710 | $1,145,637 | 2008 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
VERA
VERA THERAPEUTI...
|
Healthcare | 0.90% | 1.50% |
#28
6
Prev: #22
|
0.4 |
—
|
-11,285 | -30.6% |
P
S
|
25,573 | $1,084,641 | 2023 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
RCUS
ARCUS BIOSCIENC...
|
Healthcare | 0.86% | 1.09% |
#29
1
Prev: #28
|
0.3 |
—
|
-11,875 | -20.9% |
P
S
|
45,070 | $1,035,504 | 2020 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ROIV
ROIVANT SCIENCE...
|
Healthcare | 0.84% | 0.79% |
#30
6
Prev: #36
|
0.3 |
—
|
-12,847 | -28.3% |
P
S
|
32,500 | $1,016,368 | 2022 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
MDT
MEDTRONIC PLC
|
Healthcare | 0.80% | — |
#31
Prev: #—
|
3.8 |
—
|
11,100 | — |
NEW
|
11,100 | $961,815 | 2003 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
TRVI
TREVI THERAPEUT...
|
Healthcare | 0.78% | 0.85% |
#32
3
Prev: #35
|
0.8 |
—
|
-9,809 | -11.6% |
P
S
|
74,446 | $939,499 | 2025 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
COGT
COGENT BIOSCIEN...
|
Healthcare | 0.75% | 0.93% |
#33
Prev: #33
|
0.3 |
—
|
-10,545 | -32.3% |
P
S
|
22,140 | $902,398 | 2021 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
MLYS
MINERALYS THERA...
|
Healthcare | 0.74% | 0.92% |
#34
Prev: #34
|
0.8 |
—
|
-7 | -0.0% |
P
S
|
31,618 | $895,135 | 2023 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ALNY
ALNYLAM PHARMAC...
|
Healthcare | 0.72% | 0.95% |
#35
4
Prev: #31
|
0.3 |
—
|
-680 | -22.7% |
P
S
|
2,310 | $864,232 | 2006 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
TARS
TARSUS PHARMACE...
|
Healthcare | 0.71% | 0.97% |
#36
6
Prev: #30
|
0.3 |
—
|
-3,468 | -23.5% |
P
S
|
11,272 | $852,463 | 2024 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
RAPP
RAPPORT THERAPE...
|
Healthcare | 0.69% | 0.95% |
#37
5
Prev: #32
|
0.3 |
—
|
-13,504 | -34.7% |
P
S
|
25,421 | $835,005 | 2025 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
NKTR
NEKTAR THERAPEU...
|
Healthcare | 0.68% | 0.46% |
#38
22
Prev: #60
|
0.8 |
—
|
-2,634 | -19.5% |
P
S
|
10,851 | $820,662 | 2007 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
SNDX
SYNDAX PHARMACE...
|
Healthcare | 0.65% | 1.03% |
#39
10
Prev: #29
|
0.3 |
—
|
-29,520 | -48.2% |
P
S
|
31,680 | $787,466 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ARDX
ARDELYX INC
|
Healthcare | 0.65% | — |
#40
Prev: #—
|
3.8 |
—
|
122,394 | — |
NEW
|
122,394 | $781,060 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
PFE
PFIZER INC
|
Healthcare | 0.64% | 0.54% |
#41
7
Prev: #48
|
0.8 |
—
|
350 | 1.3% |
P
S
|
27,500 | $772,200 | 2004 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
BOLD
BOUNDLESS BIO
|
Healthcare | 0.62% | 0.65% |
#42
1
Prev: #41
|
1.2 |
—
|
no change | no change |
P
S
|
678,574 | $746,431 | 2024 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ASND
ASCENDIS PHARMA...
|
Healthcare | 0.60% | 0.56% |
#43
3
Prev: #46
|
0.7 |
—
|
-454 | -14.0% |
P
S
|
2,800 | $728,276 | 2015 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
AVBP
ARRIVENT BIOPHA...
|
Healthcare | 0.60% | 0.62% |
#44
Prev: #44
|
0.2 |
—
|
-8,242 | -21.5% |
P
S
|
30,013 | $720,430 | 2025 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
GPCR
STRUCTURE THERA...
|
Healthcare | 0.59% | 1.33% |
#45
22
Prev: #23
|
0.2 |
—
|
-9,770 | -40.9% |
P
S
|
14,102 | $710,805 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
IMTX
IMMATICS NV
|
Healthcare | 0.57% | 0.53% |
#46
5
Prev: #51
|
2.2 |
—
|
3,815 | 6.1% |
P
S
|
66,830 | $692,687 | 2025 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
BBIO
BRIDGEBIO PHARM...
|
Healthcare | 0.57% | 0.68% |
#47
8
Prev: #39
|
0.2 |
—
|
-3,070 | -27.5% |
P
S
|
8,100 | $687,276 | 2020 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
SPRY
ARS PHARMACEUTI...
|
Healthcare | 0.56% | 0.28% |
#48
18
Prev: #66
|
3.2 |
—
|
49,347 | 165.6% |
P
S
|
79,150 | $676,672 | 2022 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ONC
BEONE MEDICINES...
|
Healthcare | 0.52% | 0.65% |
#49
7
Prev: #42
|
0.2 |
—
|
-795 | -29.8% |
P
S
|
1,870 | $631,061 | 2018 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
TECX
TECTONIC THERAP...
|
Healthcare | 0.52% | 0.71% |
#50
13
Prev: #37
|
0.2 |
—
|
-23,196 | -54.9% |
P
S
|
19,059 | $628,215 | 2025 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 |
Showing 1-50 of 84 holdings